FUNDING OPPORTUNITIES Pilot Projects in Cancer Research A new Pilot Project Program is now available via
the Sidney Kimmel Comprehensive Cancer Care Center to support projects
in cancer-related research. A total of $1,000,000 will be available,
sufficient for funding 5 to 10 grants at $50,000 to $100,000 per annum
for two years to each successful applicant. Funds for this new pilot project program are being provided by the Alexander and Margaret Stewart Trust, NCI GI and Breast SPORE grants. Projects on gastrointestinal cancers and breast cancers as well as those incorporating nanotechnology or novel imaging technologies are particularly welcome. Please note that that there will be no other solicitations for pilot projects for the GI and Breast SPORE grants. Grants must be submitted electronically
through a simple web form, available at: INTERNAL SUBMISSION DEADLINE: Monday, June 1, 2009 The Instrumentation for Materials Research - Major
Instrumentation Project (IMR-MIP) program in the Division of Materials
Research provides support for the design and construction of major instruments
costing more than $4 million but less than $20 million. The program
also supports the development of detailed conceptual and engineering
design for new tools for materials preparation or characterization at
major user facilities. Such instruments may include, for example, neutron
beam lines, synchrotron beam lines, and high field magnets, as well
as development of detectors and preparation environments necessary to
support materials research. This program supports two types of awards: Conceptual
and Engineering Design (CED) and Construction (CNST) awards. A CED award
will enable the proposer to do the necessary engineering design of the
instrument. A CNST proposal may only be submitted after a satisfactory
engineering design of the instrument has been completed and has been
approved by both the facility at which the instrument will be situated
and by NSF. No operating funds for projects are covered by this program.
Such costs must be supported either by the facility or the institution
at which the instrument is located or through some other source. CED
awards will be funded through continuing or standard grants for a total
of up to about $2 million per award; up to one CNST award will be funded
through a five-year cooperative agreement, for about $1 million to $4
million per year. For further information, refer to the complete program
solicitation at: http://www.nsf.gov/pubs/2009/nsf09547/nsf09547.htm. Johns Hopkins University is permitted to nominate one (1) application for this program, for either the CED or the CNST award. The deadline to submit materials for an internal review is Monday, June 1, 2009. Interested applicants should submit the following materials to Barbara Christen at bsc2@jhu.edu in the Office of the Assistant Provost for Research Administration. The subject line of your e-mail must read: "NSF 09-547 Instrumentation for Materials Research (IMR-MIP)." These materials should be submitted as one (1) PDF, arranged in the following sequence:
Note: Each applicant is responsible for his or her own applications. You should expect to receive a confirmation of receipt of materials within 48 hours of your submission. If you do not receive such an acknowledgement, please call Dr. Christen at (410) 516-5256. The selected candidate will be notified
as soon as possible. The final application must be received by the agency
no later than Monday, June 29, 2009.
Application Deadline: 5/20/09 (letter of intent) The 2009 Innovation in Clinical Research Award
competition invites Letters of Intent for clinical research with the
potential to catalyze innovative breakthroughs in the treatment of sickle
cell disease (SCD). Applicants must hold an advanced degree (MD, PhD,
MD/PhD or the equivalent) and have a faculty appointment. Junior investigators
must identify a mentor. In recognition of the importance of cross-disciplinary
collaboration, the Foundation encourages and gives high priority to
applications from co-Principal Investigators. Investigators who may
come from the same or different institutions and who have not previously
worked in SCD research but have expertise, innovative approaches and/or
novel findings that shed new light on problems of SCD are encouraged
to apply, as are women and underrepresented minorities in medicine.
For applicants who apply for or are awarded an NIH Challenge Grant in
Health and Science Research in sickle cell disease, the Foundation will
consider allowing the NIH grant to supply years 3 and 4 of a project.
Doris Duke expects to make up to four awards for this program in 2009
and will commit $450,000 over three years plus 8% indirect costs. Proposals
are due July 8, 2009, and grants will be awarded for project to
begin November 1, 2009. For more details and application instructions,
click here: www.ddcf.org/mrp-icra. Deadline: 5/28/09 To encourage bold and unconventional research
on new global health solutions, as Round 3 of a five-year, $100 million
initiative, the Grand Challenges Explorations initiative focuses on
research areas where creative, unorthodox thinking is most urgently
needed. The topic areas for which proposals will be accepted in this
round are:
The initiative is open to any applicant
from any discipline, from student to tenured professor, and from any
organization -universities, government laboratories, research institutions,
non-profit organizations and for-profit companies. Applications are two pages, and preliminary
data about the proposed research are not required. The foundation and
an independent group of reviewers will select the most innovative proposals,
and grants will be awarded within approximately three months from the
proposal submission deadline. Initial grants will be for $100,000. Successful
projects may receive a follow-on grant of $1 million or more. For more
details and application instructions, click here: http://www.grandchallenges.org/explorations
Application Deadline: 6/1/09 (letters of intent) This program is designed to address scientific
issues related to preterm birth by bringing together a diverse interdisciplinary
group with expertise in genetics/genomics, immunology, microbiology,
proteomics, and the more traditional areas of parturition research such
as maternal fetal medicine, obstetrics, and pediatrics. This is a new
initiative of the Burroughs Wellcome Fund, which has suspended all other
programs for the 2009-10 funding year. Planning grants may be used for,
but not limited to, travel for meetings between members of research
groups, sample acquisition for later proposed studies, collection of
pilot data, and resources to support protocol generation. Personnel
costs, analysis costs, consumable supplies, animal studies, and human
subject recruitment also may be supported by the planning grant. Up
to $600,000 over four years is available for research grants. (The amount
to be awarded for planning grants is not specified). The application
deadline for a full research grant for those who are invited to apply
is December 1, 2010. Funding is expected to begin in 2011. For more
details or to apply, click here: http://www.bwfund.org/pages/363/PTBI-/ Pre-Proposal Deadline: 6/1/09 The purpose of this program is to provide
funding for early-career researchers who have innovative new ideas aimed
at the prevention, diagnosis, or treatment of cancer, but lack sufficient
preliminary data to obtain traditional funding. Basic and clinical research
projects will be considered. Assistant professors within three years
of obtaining their position or senior clinical fellows who are pursuing
independent research are eligible. Applicants with a background in multiple
disciplines are especially encouraged to apply. Applications will be evaluated on the basis
of the investigator's capacity to conduct bold, exceptionally creative
research; novelty and potential for breakthrough; innovation of proposed
research; likelihood that it will lead to significant advances; and
investigator's lack of resources to pursue research. The Foundation
plans to interview finalists in the Fall, and notify awardees in December
and is committing $450,000 over three years. Funding will begin January
1, 2010. For more details and to apply, click here:
http://www.damonrunyon.org/for_scientists/more/innovation_award_overview#program
BTFC seeks to fund research that contributes towards
progress against adult and pediatric glioma. BTFC will invest in the
development of new tools and approaches that will lead to the non-invasive
(or minimally-invasive) determination of tumor responsiveness to experimental
interventions in clinical trials and the treatment of brain tumors in
patients. Details and application instructions are posted at http://www.braintumorfunders.org.
To facilitate the design, development, feasibility
testing, and validation of non- (or minimally-) invasive response markers
the BTFC will support up to ten 1 year grants with budgets up to, but
not exceeding $100,000 direct costs. BTFC policies do not permit indirect
cost recoveries. Following review of each funded project's progress,
the BTFC could provide additional support as warranted to the projects
demonstrating the greatest likelihood of continued success and accomplishment
of the overarching goal of bringing new tools into widespread use. The
application deadline is June 15, 2009. |
|
||||||||
|
|
|
|
|
JHM Appointments | Employment @ JHM | Finding a Doctor | Disclaimer | Maps & Directions | Contact JHM |
|
|